Location History:
- Leverkusen, DE (2001)
- Odenthal-Holz, DE (2004)
Company Filing History:
Years Active: 2001-2004
Title: The Innovations of Günther Eberz
Introduction
Günther Eberz, an inventive mind headquartered in Odenthal-Holz, Germany, has made significant contributions to the field of materials science and medical technologies. With a total of two patents to his name, Eberz's innovations demonstrate a commitment to enhancing medical applications through advanced materials.
Latest Patents
Eberz's most notable patents include:
1. **Moulded bodies made of thermoplastic polyurethane containing an active substance**: This invention focuses on the development of moulded items from thermoplastic polyurethanes (TPUs), with particular emphasis on medical articles such as central venous catheters. These catheters incorporate a homogeneous distribution of antibiotic substances, enhancing their effectiveness in preventing infections. The patent also outlines a comprehensive process for preparing these active substance-containing TPUs.
2. **Analytical process for testing mixtures for toxic constituents**: This innovative analytical method begins with the chromatography-based separation of mixtures suspected of containing toxic components. The separated fractions are then exposed to luminescent microorganisms within the chromatographic system, allowing for the toxicity of each fraction to be assessed through bioluminescence measurement. This process can be conducted using either thin layer chromatography or column liquid chromatography, showcasing a novel approach to toxicological testing.
Career Highlights
Eberz is associated with Bayer Aktiengesellschaft, a leading global enterprise dedicated to the life sciences, particularly in health care and agriculture. His role in this prestigious company allows him to spearhead innovative projects and contribute to advancements in medical technology.
Collaborations
Throughout his career, Eberz has worked alongside renowned professionals in the industry, including Wolfgang Kreiss and Reinhard Albers. This collaborative environment fosters the exchange of ideas and enhances the potential for groundbreaking innovations.
Conclusion
Günther Eberz exemplifies the spirit of innovation, particularly in the domains of medical applications and analytical processes. His patents not only reflect his expertise but also contribute significantly to advancements that can improve patient care and safety. As he continues to develop new technologies, Eberz's impact on the field is expected to grow, highlighting the essential role of inventors in shaping the future of health care.